Project Details
Description
ABSTRACT
The intestinal epithelium exhibits rapid turnover mediated by intestinal stem cell (ISCs). Although Lgr5+
CBC cells have been well-accepted as the homeostatic ISC responsible for tissue regeneration, the
Yan lab at Columbia University Medical Center has recently identified a putative new stem/progenitor
cell located in the upper crypt “TA zone” region that is characterized by high-level expression of
FGFBP1, a fibroblast growth factor carrier protein that is known to play a role in cell proliferation,
differentiation, and migration. In vivo lineage tracing suggests Fgfbp1+ cells in the upper crypt give rise
to Lgr5+ cells that repopulate the crypt base as well as cells that migrate in the opposite direction to
replenish differentiated cells that line the villus that suggest their ISC function during homeostasis.
However, the signals that regulate Fgfbp1+ cell function, their cellular role in tissue injury-repair, and
our ability to harness their regenerative potential ex vivo remain completely unknown. Collaborative
studies that leverage the collective expertise of the ISCC will address these gaps in our knowledge of
Fgfbp1+ upper crypt cells using tissue injury models, diverse organoid platforms, and Wnt signaling
niche manipulation. ISCC labs at Columbia, Cincinnati Children’s Medical Center, Stowers Institute for
Medical Research, and our lab at Baylor College of Medicine (BCM) will collaboratively (1) Determine
the cellular contribution of Fgfbp1+ cells in rotavirus-induced regeneration; (2) Determine the essential
role of the Fzd 5 axis in Fgfbp1+ cells; and (3) Evaluate the ability of in vitro enteroid and organoid
platforms to support Fgfbp1+ cells. These studies build on our ongoing studies in the parent U01 grant
that are contributing to advancing the ISCC Trans-Consortium overarching goals of defining the
essential niche component that contribute to intestinal epithelial homeostasis and that may play a role
in epithelial regeneration following injury. These new ancillary studies complement our ongoing studies
and use already established methods to evaluate the new ISC/progenitor population using new mouse
models developed at Columbia University Medical Center.
Status | Active |
---|---|
Effective start/end date | 9/15/14 → 8/31/24 |
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases: $410,733.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $130,000.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $366,638.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $366,638.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $80,188.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $375,000.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $410,733.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $83,000.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $366,638.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $366,638.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $410,733.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $426,233.00
- National Institute of Diabetes and Digestive and Kidney Diseases: $64,480.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.